Robert Andrade - May 22, 2025 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Signature
/s/ Robert Andrade
Stock symbol
FENC
Transactions as of
May 22, 2025
Transactions value $
$0
Form type
4
Date filed
5/23/2025, 04:20 PM
Previous filing
May 19, 2025
Next filing
Jun 2, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Andrade Robert CHIEF FINANCIAL OFFICER C/O FENNEC PHARMACEUTICALS, INC., PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK /s/ Robert Andrade 2025-05-23 0001468308

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Options Exercise $41.9K +8.22K +5.47% $5.10 159K May 22, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Options Options Exercise -$41.9K -8.22K -0.96% $5.10 851K May 22, 2025 Options 8.22K $5.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027.